medigraphic.com
SPANISH

Medicina Cutánea Ibero-Latino-Americana

ISSN 0210-5187 (Electronic)
  • Contents
  • View Archive
  • Information
    • General Information        
    • Directory
  • Publish
    • Instructions for authors        
  • medigraphic.com
    • Home
    • Journals index            
    • Register / Login
  • Mi perfil

2012, Number 5

<< Back Next >>

Med Cutan Iber Lat Am 2012; 40 (5)

Dyskeratosis congenita and neuroendocrine tumor

Rodrigo NB, Pont SV, Armengot CM, Molés PP, Gimeno CE, Millán PF
Full text How to cite this article

Language: Spanish
References: 13
Page: 158-161
PDF size: 125.83 Kb.


Key words:

Dyskeratosis congenita, neuroendocrine gastric tumor, telomerase.

ABSTRACT

Dyskeratosis congenita (DC) is a genodermatosis with multisystem, life-threatening complications such as malignancies. We present the case of a 37-year-old male diagnosed of DC in his infancy that developed a neuroendocrine gastric tumor and died. We also review the clinical features of the disease and emphasize the importance of performing a close surveillance of these patients due to the significant risk of malignancies.


REFERENCES

  1. Hernández Fernández RA. Telómeros y telomerasas. Rev Cubana Invest Biomed 1999; 18: 121-9.

  2. Escutia B, Esparcia A, Marí JI, Sánchez JM, Sánchez Carazo JL, Aliaga Boniche A. Cutaneous alterations, lacrimal duct atresia and pancytopenia in a young man. Rev Clin Esp 2001; 201: 545-7.

  3. Nelson ND, Bertuch AA. Dyskeratosis congenita as a disorder of telomere maintenance. Mutat Res.: Fundam Mol Mech Mutagen doi: 10.1016/j.mrfmmm.2011.06. 008.

  4. Baran I, Nalcaci R, Kocak M. Dyskeratosis congenital: clinical report and review of the literature. Int J Dental Hygi 8, 2010; 68-74.

  5. Dokal I. Dyskeratosis congenita in al its forms. Br J Haematol 2000; 110: 768-79

  6. Karalis A, Tischkowitz M, Millington GWM. Dermatological manifestations of inherited cancer syndromes in children. Br J Dermatol 2011; 164: 245-56.

  7. Baykal C, Kavak A, Gülcan P, Büyükbabani N. Dyskeratosis congenita associated with three malignancies. JEADV 2003; 17: 216- 8.

  8. Jyonouchi S, Forbes L, Ruchelli E, Sullivan KE. Dyskeratosis congenita: a combined immunodeficiency with broad clinical spectrum- a single-center pediatric experience. Pediatr Allergy Immunol 2011; 22: 313-9.

  9. Alter BP, Giri N, Savage SA, Rosenberg PS. Cancer in dyskeratosis congenita. Blood 2009; 113: 6549-57.

  10. Wick MR. Neuroendocrine neoplasia: current concepts. Am J Clin Pathol 2000; 113: 331-5.

  11. Handley TPB, McCaul JA, Ogden GR. Dyskeratosis congenita. Oral Oncology 2006; 42: 331-6.

  12. Mahiques L, Febrer I, Vilata JJ, Fortea JM. A case of dyskeratosis congenita associated with schizophrenia and two malignances. J Eur Acad Dermatol Venereol 2006; 20: 1159-61.

  13. Bruna Esteban M, Montalvá Orón E, López Delgado A, Galindo Jara P, Vázquez Prado A, Fabra Ramis R. Gastric adenocarcinoma in Zinsser-Cole-Engman syndrome. Cir Esp 2006; 80: 176-7.




2020     |     www.medigraphic.com

Mi perfil

C?MO CITAR (Vancouver)

Med Cutan Iber Lat Am. 2012;40